A 68-year-old woman with end-stage renal disease on hemodialysis presents with asymptomatic hyperkalemia (K⁺ 6.8 mEq/L, no ECG changes). She has poor dietary compliance and missed her last dialysis session. Which drug is the preferred first-line treatment for chronic management of recurrent hyperkalemia in this setting?